Clinical Significance of TP53 Abnormalities in Newly Diagnosed Multiple Myeloma
Objective: This study aimed to identify the clinical significance of TP53 and common cytogenetic abnormalities. Materials and Methods: A total of 114 patients with newly diagnosed multiple myeloma (MM) and TP53 abnormalities were selected from two large patient cohorts of collaborating hospitals fro...
Main Authors: | Fang Ye, Tongtong Wang, Aijun Liu, Yanchen Li, Ningning Li, Huan Wang, Wenming Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2021-12-01
|
Series: | Turkish Journal of Hematology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-43179 |
Similar Items
-
Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
by: Katarina K. Jovanović, et al.
Published: (2019-01-01) -
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
by: Jahangir Abdi, et al.
Published: (2017-10-01) -
Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple Myeloma
by: Xiangling Feng, et al.
Published: (2022-03-01) -
Prognosis, Biology, and Targeting of <i>TP53</i> Dysregulation in Multiple Myeloma
by: Erin Flynt, et al.
Published: (2020-01-01) -
MYC Causes Multiple Myeloma Progression via Attenuating TP53-Induced MicroRNA-34 Expression
by: Yuki Murakami, et al.
Published: (2022-12-01)